Breast Cancer Coverage from Every Angle
Editor:
William J. Gradishar, MD, FACP, FASCO
Advertisement
Advertisement

Available Clinical Trials

A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients with residual triple negative breast cancer (PERSEVERE)
A Phase II Randomized Trial of Olaparib Administered Concurrently With Radiotherapy vs Radiotherapy Alone
A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)
A Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with Early Stage Breast Cancer (PBI 3.0)
A Randomized Phase II Study of Pembrolizumab, an anti-PD-1 Antibody, in Combination with Carboplatin vs Carboplatin Alone in Breast Cancer Patients with Chest Wall Disease
A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)
A Randomized Phase II Window-of-opportunity Trial of Ruxolitinib in Patients with High Risk and Premalignant Breast Conditions
A single arm phase II study of ADjuvant Endocrine therapy, subcutaneous Pertuzumab, and Trastuzumab fixed-dose combination for patients with anatomic stage I hormone receptor-positive, HER2-positive breast cancer (ADEPT)
Dana-Farber Cancer Institute - Breast Oncology Clinical Trial Finder
Duke Cancer Institute
Facilitating Adaptive Coping with Fear of Recurrence Among Breast Cancer Survivors: A Three-Arm Randomized Controlled Trial (FACing Fear)
Fox Chase Cancer Center
Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
Huntsman Cancer Institute at the University of Utah
Mayo Clinic Cancer Center
Memorial Sloan Kettering Cancer Center
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial
Moffitt Cancer Center
Older Breast Cancer Patients: Risk for Cognitive Decline
Patient Satisfaction and Outcomes Following Completion of Radiation Therapy for Breast Cancer in African-Americans
Pre-Operative PARPi and Irradiation in Women with an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Roswell Park Cancer Institute
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
The University of Texas MD Anderson Cancer Center
Tomosynthesis Mammographic Imaging Screening Trial (TMIST) EA1151
UC San Diego Moores Cancer Center
UCSF Helen Diller Family Comprehensive Cancer Center
University of Colorado Cancer Center
University of Michigan Comprehensive Cancer Center
University of Wisconsin Carbone Cancer Center
Vanderbilt-Ingram Cancer Center
Yale Cancer Center/Smilow Cancer Hospital
Copyright © 2023 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.